media.tenor.com
kermit the frog is covering his face with his hand and says your liver be like
Alt: kermit the frog is covering his face with his hand and says your liver be like
#LiverSky is an active hashtag on Bluesky. In the last 30 days, 8 people shared 23 posts with it — around 1 a day. Activity is up 0% versus the previous week, peaking on Jul 9 with 4 posts.
media.tenor.com
kermit the frog is covering his face with his hand and says your liver be like
Alt: kermit the frog is covering his face with his hand and says your liver be like
GI and Liver PART DEUX
Starter pack by Elliot Tapper
Our family is growing #LiverSky #GIsky #MedSky # GastroSky
GIsky and LiverSky
Starter pack by Elliot Tapper
These are gastroenterologists, hepatologists, surgeons, pathologists, radiologists, nurses and all our friends
www.thelancet.com
The Lancet Gastroenterology and Hepatology: Homepage
Discover articles from The Lancet Gastroenterology & Hepatology, providing a clear, independent perspective about the clinical advances and practice-changing research shaping your specialty globally
arstechnica.com
Bluesky now platform of choice for science community
It’s not just you. Survey says: “Twitter sucks now and all the cool kids are moving to Bluesky”…
Academic Journals: Medicine
Starter pack by Eloquenti 🧪✍️📚
A comprehensive starter pack of peer-reviewed medical journals.
doi.org
IgA-Enriched Phenotype Predicts Liver-Related Events in MASLD
Publication date: Available online 15 July 2026 Source: Journal of Hepatology Author(s): Takefumi Kimura, Shun-ichi Wakabayashi, Takanobu Iwadare, Shohei Kondo, Taiki Okumura, Hiroyuki Kobayashi, Yuki Yamashita, Yuma Kamijo, Kaede Fujita, Tomoyuki Nakajima, Takuro Uchida, Tomoo Yamazaki, Mai Iwaya,
springermedicine.com
GLP-1/glucagon dual agonist rapidly reduces liver fat in MASLD and MASH
GLP-1/glucagon dual agonist DD01 reduces liver fat in MASLD/MASH at 12 weeks independent of weight loss, phase 2 trial data show.
doi.org
S100A11 regulates hepatic cholesterol metabolism and promotes steatohepatitis via non-canonical SREBP2 signaling.
Dietary cholesterol and de novo cholesterol synthesis in the liver use reciprocal coordination to maintain cholesterol homeostasis. However, high level of dietary cholesterol still promotes excessive cholesterol accumulation in the liver, leading to metabolic dysfunction-associated steatohepatitis (
www.docwirenews.com
Endoscopic Bariatric Therapy for MetALD | Docwire News
Sigh Pichamol Jirapinyo, MD, discusses results from a study evaluating endoscopic bariatric therapies as a potential treatment for MetALD.
www.springermedicine.com
Prescribing Exercise in MASLD: From Evidence to a Structured, Measurable Intervention
Exercise is a disease-modifying therapy for MASLD that has multisystem benefits, but plans should be individualized, structured, and progressive. Could a proposed new framework provide a standardized...
Today, on World Hepatitis Day, we join the global community in marking this year's theme: "Hepatitis: Let's Break It Down." a call to remove the barriers that prevent people from accessing treatment services #WorldHepatitisDay #LetsBreakItDown #HepatitisB @pippa-matt.bsky.social
youtu.be
Which new treatment options are available for hepatitis D?
YouTube video by TherVacB - Awareness & Insights on Hepatitis B
Posts are pulled live from Bluesky and cached briefly. Posts with content labels are hidden.